Cholinergic Signaling via Muscarinic Receptors Directly and Indirectly Suppresses Pancreatic Tumorigenesis and Cancer Stemness

Author:

Renz Bernhard W.ORCID,Tanaka Takayuki,Sunagawa Masaki,Takahashi Ryota,Jiang Zhengyu,Macchini Marina,Dantes Zahra,Valenti Giovanni,White Ruth A.,Middelhoff Moritz A.,Ilmer MatthiasORCID,Oberstein Paul E.ORCID,Angele Martin K.,Deng Huan,Hayakawa Yoku,Westphalen C. BenediktORCID,Werner Jens,Remotti HelenORCID,Reichert Maximilian,Tailor Yagnesh H.,Nagar KaranORCID,Friedman Richard A.,Iuga Alina C.,Olive Kenneth P.,Wang Timothy C.

Funder

HHS | NIH | National Cancer Institute (NCI)

Medical Oncology T32

National Science Foundation of China

Mitsukoshi Health and Welfare Foundation

New York State Stem Cell Science

HHS | National Institutes of Health (NIH)

Columbia University

Deutsche Krebshilfe (German Cancer Aid)

Deutsche Forschungsgemeinschaft (DFG)

Pancreatic Cancer Action Network (PanCAN)

Lustgarten Foundation

Uehara Memorial Foundation

Japanese Society of Gastroenterology

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology

Cited by 180 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3